Injectable Therapies

This indepth topic covers the different injectable therapies available for the management of high glucose levels.

Depending on your chosen CDEP level, this topic aims to support you:

Describe the effect of insulin and GLP-1 receptor agonists on blood glucose levels. Describe the effect of insulin and GLP-1 receptor agonists on blood glucose levels. 1
Show an understanding of the ongoing nature of the therapy. Show an understanding of the ongoing nature of the therapy. 2
Administer insulin and GLP-1 agonist injections competently using a safety-engineered device, where supported by local policy. Administer insulin and GLP-1 agonist injections competently using a safety-engineered device, where supported by local policy. 3
Report identified problems appropriately. Report identified problems appropriately. 4
Be aware of the local Sharps Disposal Policy as well as the European Directive on prevention from sharp injuries in the hospital and healthcare sector. Be aware of the local Sharps Disposal Policy as well as the European Directive on prevention from sharp injuries in the hospital and healthcare sector. 5
Demonstrate a basic knowledge of insulin (e.g. drug type, action, side-effects) and administration devices used locally. Demonstrate a basic knowledge of insulin (e.g. drug type, action, side-effects) and administration devices used locally. 6
Demonstrate a basic knowledge of GLP-1 receptor agonists (e.g. drug type, action, side-effects) and administration devices used locally. Demonstrate a basic knowledge of GLP-1 receptor agonists (e.g. drug type, action, side-effects) and administration devices used locally. 7
Demonstrate a high level of competency in the safe administration of insulin or GLP-1 receptor agonists. Demonstrate a high level of competency in the safe administration of insulin or GLP-1 receptor agonists. 8
Demonstrate and be able to teach the correct method of insulin or GLP-1 receptor agonist self-administration. Demonstrate and be able to teach the correct method of insulin or GLP-1 receptor agonist self-administration. 9
Examine injection procedure and injection sites for detection of lipohypertrophy, and be able to give appropriate advice for resolving poor injection sites. Examine injection procedure and injection sites for detection of lipohypertrophy, and be able to give appropriate advice for resolving poor injection sites. 10
Be aware of common insulin and management errors. Be aware of common insulin and management errors. 11
Identify correct reporting system for injectable therapy errors. Identify correct reporting system for injectable therapy errors. 12
Provide evidence of insulin safety training and demonstrate the ability to use insulin safely. Provide evidence of insulin safety training and demonstrate the ability to use insulin safely. 13
Describe circumstances in which insulin use might be initiated or altered and make appropriate referral. Describe circumstances in which insulin use might be initiated or altered and make appropriate referral. 14